These 3 dividend stocks yield more than 5% with a payout ratio of over 100%. Is a dividend cut coming?

  • Investors can look at a company’s payout ratio to help gauge whether its dividend is sustainable.

  • However, in some industries, companies use adjusted profit calculations to gauge the safety of their payouts.

  • Payout ratio alone doesn’t always tell the whole story when it comes to the quality of a dividend stock.

  • 10 Stocks We Like More Than Kenvue ›

When you’re an income-oriented investor, it can be especially difficult to find out that a company in your portfolio has decided to cut or stop paying dividends. Such a move will not only affect your dividend income, but could also cause the share price to drop significantly. You are hit on both fronts.

One way to assess the riskiness of a stock’s dividend is to look at its payout ratio, the proportion of the company’s earnings needed to cover the dividend. The higher this ratio, the riskier the dividend can be. However, this is not always the case. Some high-yielding stocks may actually have safe dividends despite their seemingly high payout ratios.

Payout ratios Kenwoo (NYSE: KVUE), Enbridge (NYSE: ENB)and Real estate income (NYSE:O) today may ring alarm bells for investors. Not only do all of them have ratios above 100%, they also have yields of more than 5% at current share prices. Should investors be concerned about whether these companies’ payouts are sustainable at current levels, or could they be good income-generating investments that can be sustained over the long term?

Image source: Getty Images.

The healthcare giant Johnson & Johnson spun off from the consumer healthcare business as Kenwoo a couple of years ago. It is not a high-growth business, and the main reason most investors would want to own its stock is the dividend. It currently yields 5.5%, more than four times that S&P 500average yield of 1.2%.

The company has been in the news recently because President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. said that if mothers take Tylenol during pregnancy, their child is more likely to develop autism. Although there is no solid scientific evidence to support this claim, Tylenol is a key drug in Kenvue’s portfolio, generating approximately $1 billion in revenue. USD of annual revenue. Such claims threaten a large 15 billion For the source of the share of USD that the business brings in each year.

Kenvue recently raised its dividend by 1.2% to $0.2075 per share. That means it distributes $0.83 per share to its shareholders over the course of the year. That’s less than $0.75 in earnings per share over the last four quarters. However, Kenvue’s free cash flow during that period was $1.6 billion, which was only slightly more than its dividend payout.

Leave a Comment